Mark S. Blumberg

Ask VT AI
View News Summary
  • German pharmaceutical company Stada plans a multi-billion-euro IPO in Frankfurt this autumn to reduce debt and provide an exit for its private equity owners.
  • US skips UN human rights review amid global criticism over concerns of politicization and selective bias.
  • Six mid-cap stocks show rising quarterly EPS, but caution is advised as not all profitable companies are poised for long-term success.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • German pharmaceutical company Stada plans a multi-billion-euro IPO in Frankfurt this autumn to reduce debt and provide an exit for its private equity owners.
  • US skips UN human rights review amid global criticism over concerns of politicization and selective bias.
  • Six mid-cap stocks show rising quarterly EPS, but caution is advised as not all profitable companies are poised for long-term success.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Mark S. Blumberg